Rhumbline Advisers Globus Medical Inc Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q3 2024

A detailed history of Rhumbline Advisers transactions in Globus Medical Inc stock. As of the latest transaction made, Rhumbline Advisers holds 305,192 shares of GMED stock, worth $28.2 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
305,192
Previous 304,846 0.11%
Holding current value
$28.2 Million
Previous $20.9 Million 4.57%
% of portfolio
0.02%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$67.08 - $73.92 $23,209 - $25,576
346 Added 0.11%
305,192 $21.8 Million
Q2 2024

Aug 01, 2024
SELL
$49.79 - $68.85 $1.18 Million - $1.63 Million
-23,698 Reduced 7.21%
304,846 $20.9 Million
Q1 2024

May 09, 2024
SELL
$51.15 - $56.52 $905,815 - $1 Million
-17,709 Reduced 5.11%
328,544 $17.6 Million
Q4 2023

Feb 08, 2024
BUY
$43.79 - $55.14 $83,157 - $104,710
1,899 Added 0.55%
346,253 $18.5 Million
Q3 2023

Nov 09, 2023
BUY
$49.1 - $62.37 $5.75 Million - $7.3 Million
117,051 Added 51.5%
344,354 $17.1 Million
Q2 2023

Aug 08, 2023
BUY
$52.61 - $59.54 $28,988 - $32,806
551 Added 0.24%
227,303 $13.5 Million
Q1 2023

May 11, 2023
BUY
$51.83 - $79.63 $21,613 - $33,205
417 Added 0.18%
226,752 $12.8 Million
Q4 2022

Feb 14, 2023
BUY
$58.4 - $75.53 $358,284 - $463,376
6,135 Added 2.79%
226,335 $16.8 Million
Q3 2022

Nov 10, 2022
BUY
$55.32 - $67.54 $30,204 - $36,876
546 Added 0.25%
220,200 $13.1 Million
Q2 2022

Aug 11, 2022
BUY
$53.08 - $81.37 $1.31 Million - $2.01 Million
24,675 Added 12.66%
219,654 $12.3 Million
Q1 2022

May 12, 2022
SELL
$63.68 - $75.54 $301,779 - $357,984
-4,739 Reduced 2.37%
194,979 $14.4 Million
Q4 2021

Feb 10, 2022
BUY
$62.62 - $79.92 $420,869 - $537,142
6,721 Added 3.48%
199,718 $14.4 Million
Q3 2021

Nov 12, 2021
SELL
$76.41 - $84.06 $405,049 - $445,602
-5,301 Reduced 2.67%
192,997 $14.8 Million
Q2 2021

Aug 05, 2021
SELL
$61.85 - $77.53 $106,629 - $133,661
-1,724 Reduced 0.86%
198,298 $15.4 Million
Q1 2021

May 06, 2021
SELL
$60.05 - $67.74 $52,003 - $58,662
-866 Reduced 0.43%
200,022 $12.3 Million
Q4 2020

Feb 10, 2021
BUY
$48.89 - $65.87 $13,884 - $18,707
284 Added 0.14%
200,888 $13.1 Million
Q3 2020

Nov 12, 2020
SELL
$45.26 - $57.82 $208,874 - $266,839
-4,615 Reduced 2.25%
200,604 $9.93 Million
Q2 2020

Aug 13, 2020
SELL
$39.81 - $55.61 $1.16 Million - $1.62 Million
-29,158 Reduced 12.44%
205,219 $9.79 Million
Q1 2020

May 06, 2020
SELL
$35.06 - $59.45 $171,688 - $291,126
-4,897 Reduced 2.05%
234,377 $9.97 Million
Q4 2019

Feb 05, 2020
BUY
$49.45 - $59.5 $85,350 - $102,697
1,726 Added 0.73%
239,274 $14.1 Million
Q3 2019

Oct 23, 2019
SELL
$40.41 - $52.32 $132,342 - $171,348
-3,275 Reduced 1.36%
237,548 $12.1 Million
Q2 2019

Aug 14, 2019
BUY
$39.3 - $48.41 $359,398 - $442,709
9,145 Added 3.95%
240,823 $10.2 Million
Q1 2019

May 01, 2019
BUY
$38.08 - $49.41 $76,160 - $98,820
2,000 Added 0.87%
231,678 $11.4 Million
Q4 2018

Jan 31, 2019
BUY
$41.38 - $57.44 $3.88 Million - $5.39 Million
93,787 Added 69.02%
229,678 $9.94 Million
Q3 2018

Nov 07, 2018
SELL
$50.24 - $56.76 $343,691 - $388,295
-6,841 Reduced 4.79%
135,891 $7.71 Million
Q2 2018

Aug 06, 2018
BUY
$47.96 - $57.41 $150,162 - $179,750
3,131 Added 2.24%
142,732 $7.2 Million
Q1 2018

May 02, 2018
SELL
$42.75 - $51.73 $493,206 - $596,809
-11,537 Reduced 7.63%
139,601 $6.96 Million
Q4 2017

Feb 09, 2018
SELL
$28.86 - $41.64 $86,262 - $124,461
-2,989 Reduced 1.94%
151,138 $6.21 Million
Q3 2017

Nov 06, 2017
BUY
$28.28 - $30.85 $4.36 Million - $4.75 Million
154,127
154,127 $4.58 Million

Others Institutions Holding GMED

# of Institutions
482
Shares Held
104M
Call Options Held
183K
Put Options Held
57.3K
View Full List

About GLOBUS MEDICAL INC

GMED Quotes by TradingView
  • Ticker GMED
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 77,037,200
  • Market Cap $7.12B
  • Description
  • Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...
More about GMED
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email